KR890003391A - 칼슘 보충제 - Google Patents

칼슘 보충제 Download PDF

Info

Publication number
KR890003391A
KR890003391A KR1019880010859A KR880010859A KR890003391A KR 890003391 A KR890003391 A KR 890003391A KR 1019880010859 A KR1019880010859 A KR 1019880010859A KR 880010859 A KR880010859 A KR 880010859A KR 890003391 A KR890003391 A KR 890003391A
Authority
KR
South Korea
Prior art keywords
calcium
citrate
maleate
malate
supplement
Prior art date
Application number
KR1019880010859A
Other languages
English (en)
Other versions
KR970009583B1 (en
Inventor
알렌 쟈콥스 스테펜
Original Assignee
원본미기재
노르위치 이튼 파마슈티칼즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 노르위치 이튼 파마슈티칼즈, 인코포레이티드 filed Critical 원본미기재
Publication of KR890003391A publication Critical patent/KR890003391A/ko
Application granted granted Critical
Publication of KR970009583B1 publication Critical patent/KR970009583B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

칼슘 보충제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 약 6 : 2 : 3의 칼슘 : 시트레이트 : 말레이트의 몰비를 갖는 칼슘 시트레이트 말레이트.
  2. 제1항에 따른 칼슘-함유 시트레이트 및 말레이트 리간드의 착화합물.
  3. 안전하며 유효한 양의 제1항에 따른 칼슘 시트레이트 말레이트 및 약제학적으로 허용되는 담체를 함유함을 특징으로 하는 칼슘 보충제.
  4. 제3항에 있어서, 칼슘 시트레이트 말레이트를 약 425mg 내지 약 2100mg함유하는 단위 용량형의 칼슘 보충제.
  5. 제3항에 있어서, 약제학적으로 허용되는 담체가 약 0.1 내지 약 75중량%의 양으로 존재하는 고체 용량형의 칼슘 보충제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR88010859A 1987-08-28 1988-08-26 Calcium supplements KR970009583B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28
US07/090,813 1987-08-28

Publications (2)

Publication Number Publication Date
KR890003391A true KR890003391A (ko) 1989-04-14
KR970009583B1 KR970009583B1 (en) 1997-06-14

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
KR88010859A KR970009583B1 (en) 1987-08-28 1988-08-26 Calcium supplements

Country Status (13)

Country Link
EP (1) EP0304987B1 (ko)
JP (1) JP2795651B2 (ko)
KR (1) KR970009583B1 (ko)
AT (1) ATE82120T1 (ko)
AU (1) AU625809B2 (ko)
CA (1) CA1314233C (ko)
DE (1) DE3875867T2 (ko)
DK (1) DK481388A (ko)
HK (1) HK182096A (ko)
IE (1) IE61452B1 (ko)
IL (1) IL87452A (ko)
NZ (1) NZ225950A (ko)
ZA (1) ZA886355B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960010009A (ko) * 1994-09-26 1996-04-20 이곤 이. 버그 개선된 칼슘 규정식 보충물

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533724B1 (en) * 1990-06-14 1995-04-26 The Procter & Gamble Company Calcium citrate malate composition
CA2102210C (en) * 1991-05-06 1998-08-04 Mark Benson Andon Combined calcium and vitamin d supplements
EP0622992B1 (en) * 1991-12-26 1998-10-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
CA2146632C (en) * 1992-10-21 1999-02-23 Alice Lyles Burkes Sweetener containing a concentrated bioavailable calcium source
CA2146633C (en) * 1992-10-21 1998-09-01 Mark Benson Andon Concentrated bioavailable calcium source
ES2089858T3 (es) * 1992-10-21 1996-10-01 Procter & Gamble Concentrados de premezcla para bebidas suplementados con calcio y estables en almacenamiento.
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品／冷蔵品およびその製造法
CN101505730B (zh) * 2006-08-17 2013-02-13 宝洁公司 包含柠檬酸苹果酸钙的组合物以及它们的制备方法
JP5140669B2 (ja) * 2006-08-17 2013-02-06 ザ プロクター アンド ギャンブル カンパニー クエン酸リンゴ酸カルシウムを含む組成物及びその製造方法
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
CN104114179A (zh) * 2011-12-13 2014-10-22 艾玛菲克有限公司 用于治疗钙吸收不良和骨代谢紊乱的无定形碳酸钙
CN107921060A (zh) 2015-06-04 2018-04-17 艾玛菲克有限公司 用于吸入施用、舌下施用或含服施用的无定形碳酸钙的组合物
IL294615A (en) 2016-10-25 2022-09-01 Amorphical Ltd Amorphous calcium carbonate for the treatment of leukemia
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) * 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960010009A (ko) * 1994-09-26 1996-04-20 이곤 이. 버그 개선된 칼슘 규정식 보충물

Also Published As

Publication number Publication date
DE3875867D1 (de) 1992-12-17
KR970009583B1 (en) 1997-06-14
DE3875867T2 (de) 1993-04-01
ATE82120T1 (de) 1992-11-15
IE882610L (en) 1989-02-28
EP0304987A2 (en) 1989-03-01
CA1314233C (en) 1993-03-09
EP0304987A3 (en) 1990-02-21
JPH01156985A (ja) 1989-06-20
IE61452B1 (en) 1994-11-02
ZA886355B (en) 1989-05-30
AU625809B2 (en) 1992-07-16
EP0304987B1 (en) 1992-11-11
NZ225950A (en) 1991-10-25
HK182096A (en) 1996-10-11
DK481388A (da) 1989-03-02
AU2159888A (en) 1989-06-15
JP2795651B2 (ja) 1998-09-10
DK481388D0 (da) 1988-08-29
IL87452A0 (en) 1989-01-31
IL87452A (en) 1992-07-15

Similar Documents

Publication Publication Date Title
KR890003391A (ko) 칼슘 보충제
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
KR880010764A (ko) 과콜레스테롤혈중 치료용 혼합물
DE69224809D1 (de) Thyroaktive Zusammensetzung mit kontrollierter Freigabe
ZA876731B (en) Therapeutic agents
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
KR920019350A (ko) 자기면역질환요법을 위한 약제조성물
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
JPS5781409A (en) External plaster
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
ES404959A1 (es) Un procedimiento para preparar una composicion acuosa es- table de dexiciclina.
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
GB2258397A (en) Pharmaceutical compositions containing amethocaine
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
SE8704240D0 (sv) Analgesic preparations
KR880001293A (ko) 안티트롬빈 작용을 가지는 활성 물질 조합
IT1224250B (it) Associzione del depiprazolo con la morfina
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
IL79207A (en) Geriatric pharmaceutical compositions containing terguride for treatment of cognitive and psychic disorders due to dopamine hypofunction
KR890012651A (ko) 이뇨제 또는 항고혈압제 조성물
MY100752A (en) Pharmaceutical composition for combating malaria.
KR880000094A (ko) 위염치료제
DE3786168D1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20111019

Year of fee payment: 15

EXPY Expiration of term